| Rimonabant Basic information | |
| Product Name: | Rimonabant |
| Synonyms: | ACOMPLIA; RIMONABANT; RIMONABANT(ACOMPLIA,SR141716); 5 – (4 – Chlorophenyl) – 1 – (2, 4 – dichlorophenyl) – 4 – methyl – N – piperidinopyrazole – 3 – carboxamide; xibuqum; 1 h – Pyrazole – 3 – carboxamide, 5 – (4 – chlorophenyl) – 1 – (2, 4 – dichlorophenyl) – 4 – methyl – N – 1 – piperidinyl – |
| CAS: | 168273-06-1 |
| MF: | C22H21Cl3N4O |
| MW: | 463.79 |
| EINECS: | 200-223-5 |
| Product Categories: | Raw material intermediates – apis; Weight loss raw materials; Health care raw materials; Anti-fat drugs; Pharmaceutical raw materials; Small molecule inhibitor; Active pharmaceutical ingredients. G protein-coupled receptor &G protein; To lose weight |
| Application | Rimonabant is a new weight loss drug and can be applied to smoking cessation. It also lowers blood pressure, cholesterol and blood sugar. |
| Rimonabant Chemical Properties | |
| Melting point | 154.7 °C |
| Density | 1.41±0.1 g/cm3(Predicted) |
| Solubility | Soluble in DMSO (up to 20 mg/ml) or in Ethanol (up to 20 mg/ml). |
| form | Powder. |
| color | White to off-white crystalline |
| pKa | 11.31±0.20(Predicted) |
